===== SYNERGY: Empagliflozin has received a drug registration certificate in South Korea =====

According to the Zhitong Finance APP, SYNERGY announced that the company recently received the drug registration certificate for Empagliflozin issued by the Ministry of Food and Drug Safety (MFDS) of South Korea, which is suitable for the treatment of type 2 diabetes

According to the Zhitong Finance APP, SYNERGY (300636.SZ) announced that the company recently received the drug registration certificate for Empagliflozin issued by the Ministry of Food and Drug Safety (MFDS) of South Korea, which is suitable for the treatment of type 2 diabetes